- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BNT162b2 (Pfizer)
Total 814 results
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 Infection | Maternal ImmunizationUnited States, United Kingdom, Spain, Brazil, South Africa
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
PfizerCompleted
-
BioNTech SEShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Completed
-
PfizerActive, not recruitingCOVID-19 | Influenza, Human | SARS-CoV-2 InfectionUnited States
-
Pontificia Universidad Catolica de ChileRecruitingSars-CoV-2 InfectionChile
-
BioNTech SEPfizerActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
Humanity & Health Medical Group LimitedCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedCovid19 | SARS-CoV2 InfectionUnited States
-
Montefiore Medical CenterAlbert Einstein College of MedicineRecruiting
-
The University of Hong KongActive, not recruiting
-
BioNTech SECompletedCOVID-19 | SARS-CoV-2 InfectionGermany
-
National Institute of Allergy and Infectious Diseases...Completed
-
The University of Hong KongActive, not recruiting
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedHealthy | Immunization; InfectionFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
University of DebrecenCompletedBasic BBIBP-CorV Vaccination is Not as Effective as BNT162bHungary
-
Assistance Publique - Hôpitaux de ParisRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute LeukemiaFrance
-
Assistance Publique - Hôpitaux de ParisCOVIREIVACActive, not recruiting
-
University of Roma La SapienzaICOT University HospitalRecruiting
-
Medical University of ViennaActive, not recruiting
-
Korea University Guro HospitalAjou University School of Medicine; Korean Center for Disease Control and Prevention and other collaboratorsRecruitingInflammation | Vaccine Adverse Reaction | Vaccine Immune Response | COVID-19 VaccinationKorea, Republic of
-
Ente Ospedaliero Ospedali GallieraUniversity of GenoaRecruitingNeoplasms | Cancer, Treatment-RelatedItaly
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
GreenLight Biosciences, Inc.Withdrawn
-
Butantan InstituteActive, not recruitingCoronavirus Infections | HealthyBrazil
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
Ain Shams UniversityRecruiting
-
Umeå UniversityNot yet recruitingCovid19 | Vaccination; Infection
-
BioNTech SECompletedCovid-19 | Protection Against COVID-19Germany
-
BioNTech SEShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Completed
-
Hospital General Universitario ElcheCompletedIron Deficiency Anemia
-
National and Kapodistrian University of AthensRecruitingCOVID-19 | Chronic Disease | Solid Tumor | Healthy Volunteers | Hematological MalignanciesGreece
-
Rigshospitalet, DenmarkInnovation Fund Denmark; Ministry of Education, DenmarkRecruitingMyocarditis | SARS-CoV2 Infection | Myopericarditis | Vaccination; Complications | COVID-19 PandemicDenmark
-
Assistance Publique - Hôpitaux de ParisCOVIREIVACActive, not recruitingAdult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second DoseFrance
-
Institut Pasteur de TunisCompleted
-
Chang Gung Memorial HospitalMedigen Vaccine Biologics Corp.Active, not recruitingCOVID-19 | Breakthrough InfectionTaiwan
-
Hong Kong Sanatorium & HospitalCompletedCovid-19 VaccineHong Kong
-
Pontificia Universidad Catolica de ChileCompletedCOVID-19 | SARS-CoV-2 Infection | Solid Organ Transplant | Vaccine Response ImpairedChile
-
Jeppe Lange, MDCompletedDupuytrens ContractureDenmark
-
The University of Hong KongActive, not recruiting
-
University of ArizonaCompletedCancer | Covid19 | Malignancy | Vaccine Response ImpairedUnited States
-
Klinikum LudwigshafenPfizerUnknownAge-related Macular DegenerationGermany
-
PfizerCompletedRheumatoid ArthritisUnited States, Australia, Canada, Israel, Mexico, Colombia, Germany, Russian Federation, South Africa, United Kingdom
-
The University of Hong KongActive, not recruiting
-
RespiralabCompletedAdverse Drug EventEcuador
-
PfizerRecruitingCOVID-19 | SARS-CoV-2 | Post-Acute COVID-19 SyndromeUnited States
-
Johns Hopkins UniversityRecruitingCOVID-19 | Pregnancy; InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedSystemic Allergic ReactionUnited States